Jump to search

January 2021

UC Davis receives $3.2 million grant to study age-related macular degeneration

January 19, 2021

Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science, has been awarded a five-year, $3.2 million grant from the National Institutes of Health National Eye Institute for a study on age-related macular degeneration, or AMD.

Fewer behavior problems in young foster care kids after PC-CARE program

January 14, 2021

A new study finds that young children in the foster care system demonstrated fewer behavior problems after participating in an innovative seven-week intervention. The program is called PC-CARE, and was pioneered at UC Davis CAARE Center.

Exposure to violence takes a toll on the socioemotional well-being of Californians

January 14, 2021

A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.

Research on COVID-19 vaccine includes data from UC Davis School of Medicine

January 13, 2021

The New England Journal of Medicine published a peer-reviewed paper on the newly available Pfizer COVID-19 vaccine. It includes clinical trial data collected from UC Davis Health, the only academic medical center on the West Coast to take part in the study.

Innovative serotonin sensor to improve neurological drug development

January 11, 2021

UC Davis researchers developed and used an innovative sensor to track serotonin in the brains of mice during social interactions, fearful situations and sleep/wake conditions. Sensor can help in developing better neuropsychological drugs for depression and other conditions.

Concerns about violence increase in California amid COVID-19 pandemic

January 4, 2021

Study finds that people in California are more worried about violence during COVID-19 pandemic.

December 2020

UC Davis Health launches new COVID-19 vaccine trial

December 30, 2020

Participants are needed for a new clinical trial at UC Davis Health to test another experimental COVID-19 vaccine that could help address the global pandemic.

Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication

December 21, 2020

UC Davis Health scientists joined a landmark multicenter clinical trial to test the ability of a type of stem cells to treat patients with acute respiratory distress syndrome (ARDS), a life-threatening lung injury.

Big brains and white matter: New clues about autism subtypes

December 17, 2020

Researchers found that a long-accepted theory about brain size in some children with autism may not be true. In a separate study, they linked development of white matter with changes in autism symptom severity.

Wildfire smoke can carry microbes that cause infectious diseases

December 17, 2020

Wildfire smoke contains microbes, a fact that’s often ignored, but one that may have important health repercussions.

Risk factors for Valley fever among Hispanic California farmworkers

December 15, 2020

Valley fever exposure might be higher in certain agricultural tasks and types of crops, according to Prof. Stephen McCurdy’s research.

UC Davis Health is prepared to receive Pfizer COVID-19 vaccine

December 10, 2020

With an allotment of Pfizer’s COVID-19 vaccine to arrive as early as Monday, UC Davis Health is preparing its storage space and its employees for one of the most significant inoculation efforts in recent history.

Hydrogen peroxide keeps gut bacteria away from the colon lining

December 9, 2020

An enzyme in the colon lining releases hydrogen peroxide – a known disinfecting compound- to protect the body from gut microbial communities. The new study points to the need for a different approach to treating gut inflammation and bacterial imbalance in the colon.

Neurologist Michael Rogawski named fellow of the National Academy of Inventors

December 8, 2020

Michael Rogawski has been elected a fellow of the National Academy of Inventors, the highest professional distinction given to academic inventors, for his inventions in drug discovery and development.

UC Davis Health joins Novavax in testing a new COVID-19 vaccine

December 7, 2020

UC Davis Health launches a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.

Kidney and brain injuries linked to diabetic ketoacidosis

December 4, 2020

UC Davis Health experts have identified factors that make children with diabetic ketoacidosis more likely to experience acute kidney injury. The results may eventually lead to new options and better treatments for the dangerous condition. 

November 2020

Obesity affects stem cell transplants for cancer, blood disorder treatments

November 25, 2020

Led by a UC Davis Health team, researchers have found that obesity can block the benefits of a stem cell transplant when it is used for treating blood cancers and other related disorders.

School of Medicine team contributes to special issue of Birth Defects Research

November 18, 2020

A UC Davis research team, consisting of postdoctoral fellows, graduate students and undergraduates led by Chengji Zhou, professor of biochemistry and molecular medicine at the UC Davis School of Medicine, has made major contributions to the latest issue of Birth Defects Research. This issue was published online this month.

Breathing problems in teens: COVID-19 or lung injury due to vaping?

November 17, 2020

Lung injury due to e-cigarette use (EVALI) and COVID-19 share many symptoms. Providers need to get the vaping history of teenagers with unexplained breathing problems.

State stem cell agency funds clinical trial for spina bifida treatment

November 12, 2020

California’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.

Young survivors of acute myeloid leukemia have long-term complications from treatment

November 9, 2020

Adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing several long-term health complications after treatment.

Does breastfeeding lower mother’s breast cancer risk?

November 5, 2020

Less than 40% of women in the U.S. know that breastfeeding lowers breast cancer risk.

Jennifer Doudna on CRISPR, coronavirus and curiosity-driven research

November 3, 2020

2020 Nobel Laureate Jennifer Doudna gave a fascinating talk on CRISPR and its potential to improve diagnosis and treatment of COVID-19.